Mechanisms of resistance to chemotherapy in non-small cell lung cancer
Hye-Young Min et al, 2021, Archives of Pharmacal Research CrossRef
Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer
Ryosuke Tanino et al, 2018, Oncotarget CrossRef
Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer
Shachar Raz et al, 2016, Drug Resistance Updates CrossRef
Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients
M. Teresa Agulló-Ortuño et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
An RNAi therapeutic, DFP-10825, for intraperitoneal and intrapleural malignant cancers
Hidenori Ando et al, 2020, Advanced Drug Delivery Reviews CrossRef
The role of thymidylate synthase in non-small cell lung cancer treated with pemetrexed continuation maintenance therapy
Min Yang et al, 2017, Journal of Chemotherapy CrossRef
Association of expression and genotypes of thymidylate synthase in non-small cell lung cancer patients with different clinicopathological characteristics
Jin-Yin Chen et al, 2021, Pteridines CrossRef
Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis
Shinnosuke Takemoto et al, 2021, Thoracic Cancer CrossRef
Establishment and Characterization of Pemetrexed-resistant NCI-H460/PMT Cells
Yu-Lian Xu et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells
Yiyang Qin et al, 2017, Cancer Cell International CrossRef
Predictive value of thymidylate synthase for the prognosis and survival of lung adenocarcinoma patients
YAN HUANG et al, 2015, Oncology Letters CrossRef
Gastrodin destabilizes survivin and overcomes pemetrexed resistance
Jinzhuang Liao et al, 2023, Cellular Signalling CrossRef